First Trust Capital Management’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-299,998
Closed -$3.17M 204
2026
Q1
$3.17M Sell
299,998
-350,000
-54% -$3.69M 0.17% 118
2025
Q4
$6.82M Hold
649,998
0.41% 64
2025
Q3
$6.73M Hold
649,998
0.43% 57
2025
Q2
$6.68M Hold
649,998
0.45% 56
2025
Q1
$6.55M Buy
+649,998
New +$6.53M 0.47% 54

Other funds holding TDAC

First Trust Capital Management's TDAC Position: Q2 2026 in Review

First Trust Capital Management sold out of Translational Development Acquisition Corp (TDAC) in Q2 2026, closing a stake of 299,998 shares — an estimated $3.17M sold.

First Trust Capital Management first reported a position in TDAC in Q1 2025 and held it in 5 quarters. The position peaked at $6.82M in Q4 2025. 29 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • First Trust Capital Management reported no remaining Translational Development Acquisition Corp position as of Q2 2026 after selling out during the quarter.
  • First Trust Capital Management sold 299,998 Translational Development Acquisition Corp shares in Q2 2026, an estimated $3.17M.
  • First Trust Capital Management first reported a position in Translational Development Acquisition Corp in Q1 2025 and held it in 5 quarters.
  • First Trust Capital Management's Translational Development Acquisition Corp position peaked at $6.82M in Q4 2025.
  • 29 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on First Trust Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.